Apl Sales I LLC
UnclaimedPharmaceutical Preparation ManufacturingWaltham, MA
Founded
2009
Primary NAICS
325412
CAGE code
8XB84
Federal awards
$746.1K
Overview
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 5 |
| 2025 | Department of Veterans Affairs | $155,762 | 11 |
| 2024 | Department of Veterans Affairs | $334,507 | 18 |
| 2023 | Department of Veterans Affairs | $255,857 | 15 |
| 2022 | Department of Veterans Affairs | $0 | 5 |